Los Angeles Business Journal

LA HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

FDA Recommends Amgen Cholesterol Drug

A regulatory advisory panel on Wednesday recommended approval for Repatha, a new cholesterol drug from Amgen Inc., although use should be limited to patients with high risk of heart disease.

FDA to Weigh Amgen’s Repatha

Health regulators have decided a new drug from Amgen Inc. reduces “bad” cholesterol, but they aren’t sure it’s for everyone.

Puma Tumbles After Presentation

Puma Biotechnology Inc. got a mixed reception from physicians Monday morning after the company shared additional data from its pivotal breast cancer drug trial at the American Society of Clinical Oncology’s annual meeting in Chicago.

Children’s Hospital Expands to Encino

Children’s Hospital Los Angeles on Monday opened a new outpatient care center in Encino, the Los Feliz institutions fifth outpost opened over the past few years. Opening satellite sites is a popular practice among local hospitals, which see them as a cheaper way to expand their services while also helping bring in more patients who are privately insured. See more on the hospital’s strategy in the latest edition of the Business Journal.

Amgen, Merck Expand Cancer Research

Amgen Inc. will expand its collaboration with Merck on research seeking a cure for a special type of head and neck cancer, the company announced Friday.

Friday Rundown: Puma Report On Tap, LAX Traffic Takeoff Continues, Zipcar and Metro Team Up

Puma to Unpack Drug Study Puma Biotechnology Inc. on Monday morning will reveal additional details from a pivotal study of its breast cancer drug at the American Society of Clinical Oncology’s annual meeting in Chicago.

Suicide Concerns Dissolve Amgen Partnership

Amgen Inc. will end a partnership to develop a drug for psoriasis because it could face restrictive labeling due to concerns from regulatory agencies that it might lead to suicidal thoughts.

E.U. Panel Backs Amgen Cholesterol Drug

Amgen Inc. announced Friday that a European Union committee has recommended approval of its drug Repatha to treat high cholesterol.

DaVita Consolidates in Large El Segundo Lease Deal

DaVita HealthCare Partners Inc. wanted to “DaVita-ize” its California presence.

Molina Continues Expansion with Michigan Buy

Long Beach’s fast-growing managed care provider Molina Healthcare Inc. plans to add to its Medicaid contract holdings, announcing plans Friday to acquire the Medicaid contract businesses of HealthPlus of Michigan Inc. and its subsidiary, HealthPlus Partners Inc. through Molina’s Michigan subsidiary.

Puma Shares Fall on Study Results

Puma Biotechnology Inc. shares took a nosedive on Thursday in the wake of newly released data from a clinical trial for its breast cancer drug neratinib.

Health Net Shifts 2,000 Employees to Contractor

More than 2,000 employees are being laid off Health Net Inc. but will be offered jobs with information technology contractor Cognizant Technology Solutions Corp. as part of a multi-year agreement, the health insurer said Wednesday.

Soon-Shiong’s NantWorks Unit Gets $100 Million Infusion

A subsidiary of billionaire Patrick Soon-Shiong’s NantWorks health care technology company has secured $100 million in equity funding, according to regulatory filings.

Amgen Granted Novartis Injunction

An appeals court has blocked sales of Zarxio, a copycat version of Amgen Inc.’s blockbuster drug Neupogen.

Briefs: Tutor Perini Wins New York Contract, Molina Tops Estimates

Tutor Perini Corp. Gets $56.3 Million Contract Tutor Perini Corp. has won a $56.3 million contract from Amtrak for the Hudson Yards project in New York City.